Poolbeg Pharma PLC (AIM:POLB)
London · Delayed Price · Currency is GBP · Price in GBX 6.90
+0.05 (0.73%)
Jul 6, 2026, 12:34 PM GMT
Poolbeg Pharma Market Cap
Poolbeg Pharma has a market cap or net worth of 48.3 million as of July 6, 2026. Its market cap has increased by 138.88% in one year.
Market Cap
48.30M
Enterprise Value
40.59M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.90
Market Cap Chart
Since July 19, 2021, Poolbeg Pharma's market cap has decreased from 53.75M to 48.30M, a decrease of -10.14%. That is a compound annual growth rate of -2.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 48.30M | 73.19% |
| Dec 31, 2025 | 27.89M | -21.44% |
| Dec 31, 2024 | 35.50M | -21.55% |
| Dec 29, 2023 | 45.25M | 49.59% |
| Dec 30, 2022 | 30.25M | -36.32% |
| Dec 31, 2021 | 47.50M | -11.63% |
| Jul 19, 2021 | 53.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Faron Pharmaceuticals Oy | 94.23M |
| Bioventix | 83.60M |
| 4basebio | 81.58M |
| Ondine Biomedical | 77.41M |
| Hemogenyx Pharmaceuticals | 52.36M |
| hVIVO | 49.12M |
| Sareum Holdings | 29.10M |
| SkinBioTherapeutics | 27.21M |